Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 6/20 | 0.31 |
| ▸ | NOS3 | P29474 | 5/20 | 0.31 |
| ▸ | NOS2 | P35228 | 5/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6898227 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL598869 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL11252107 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL4616915 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL283721 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL23952890 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL6250904 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL7724695 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL6894837 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 | |
| SCHEMBL6897202 | 1.00 | CA1 (0.46) | CA1CA2CA4ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3660027-A1 | THERMOSETTING RESIN COMPOSITION, PREPREG MADE THEREFROM, LAMINATE CLAD WITH METAL FOIL, AND HIGH-FREQUENCY CIRCUIT BOARD | Shengyi Technology Co., Ltd. (CN) | 2020-06-03 | — | — | EP | disclosed |
| EP-3660026-A1 | THERMOSETTING RESIN COMPOSITION, PREPREG MADE THEREFROM, LAMINATE CLAD WITH METAL FOIL, AND HIGH-FREQUENCY CIRCUIT BOARD | Shengyi Technology Co., Ltd. (CN) | 2020-06-03 | — | — | EP | disclosed |
| US-9963451-B2 | Fused ring pyrimidine compound and pest control agent containing the same | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20150368249-A1 | FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2015-12-24 | — | — | US | disclosed |
| EP-2418723-A1 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | Mitsubishi Chemical Corporation (JP) | 2012-02-15 | — | — | EP | disclosed |
| EP-1549668-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | Karyon OY (FI) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004031221-A9 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004031219-A1 | TUMOR TARGETING AGENTS AND USES THEREOF | KARYON OY (FI) | 2004-04-15 | — | — | WO | disclosed |
| CN-1139632-C | Polypropylene resin composition and its use | 三井化学株式会社 | 2004-02-25 | — | — | CN | disclosed |
| CN-1076031-C | Polypropylene resin composition and application thereof | MITSUI PETROCHEMICAL IND (JP) | 2001-12-12 | — | — | CN | disclosed |
| CN-1304955-A | Polypropylene resin composition and its use | MITSUI CHEMICALS INC (JP) | 2001-07-25 | — | — | CN | disclosed |
| CN-1102419-A | Polypropylene resin composition and application thereof | MITSUI PETROCHEMICAL IND (JP) | 1995-05-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368249-A1 | FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME | CBR3, HRH2, HRH4 | CA1 4146/4885CA2 2647/4885CA4 4113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.